Risk for gastric cancer after antibiotic prophylaxis in patients undergoing hip replacement

Cancer Research

Volumn 60, Issue 22, 2000, Pages 6376-6380

  Akre, K ^a   Signorello, L B ^a   Engstrand, L ^a   Bergstrom, R ^a   Larsson, S ^a   Eriksson, B I ^a   Nyren, O ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CANCER RISK; COHORT ANALYSIS; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROCONVERSION; SEX DIFFERENCE; STOMACH CANCER; TOTAL HIP PROSTHESIS;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBIOTIC PROPHYLAXIS; ANTIBODIES, BACTERIAL; ARTHROPLASTY, REPLACEMENT, HIP; ASPIRIN; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RISK FACTORS; STOMACH NEOPLASMS;

EID: 0033708713     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils
2. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils
3. Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil
4. Cancer risk after hip replacement with metal implants: A population-based cohort study in Sweden
5. Hip and knee implantations among patients with osteoarthritis and risk of cancer: A record-linkage study from Denmark
6. Seroepidemiology of Helicobacter pylori infection in heart transplant recipients
7. Prevalence of serum antibodies to Helicobacter pylori and to CagA protein in liver transplant recipients
8. Time trends in incidence rates of first hip fracture in the Uppsala Health Care Region, Sweden, 1965-1983
9. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978
10. An accurate, rapid and convenient physician-office serologic test for detection of Helicobacter pylori infection
11. Evaluation of three commercial enzyme immunoassays compared with the 13C urea breath test for detection of Helicobacter pylori infection
12. Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: Development of a biomarker strategy for gastric atrophy in high risk groups
13. Plasma pepsinogens, nutrients, and diet in areas of Italy at varying gastric cancer risk
14. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia
15. The epidemiology of low serum pepsinogen A levels and an international association with gastric cancer rates. EUROGAST Study Group
16. Prospective study of social influences on mortality. The study of men born in 1913 and 1923
17. Analysis of quantitative data by quantiles in epidemiologic studies: Classification according to cases, noncases, or all subjects?
18. Seroconversion and seroreversion in IgG antibodies to Helicobacter pylori: A serology based prospective cohort study
19. Increasing prevalence of Helicobacter pylori infection with age: Continuous risk of infection in adults rather than cohort effect
20. Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study
21. Susceptibility of Campylobacter pyloridis to 20 antimicrobial agents
22. The E test for antimicrobial susceptibility testing of Helicobacter pylori
23. The role of acid inhibition in the treatment of Helicobacter pylori infection
24. Prolonged and profound acid inhibition is crucial in Helicobacter pylori treatment with a proton pump inhibitor combined with amoxicillin
25. Additive effect of clarithromycin combined with 14-hydroxy clarithromycin, erythromycin, amoxycillin, metronidazole or omeprazole against Helicobacter pylori
26. Helicobacter pylori and gastric carcinogenesis
27. Atrophic gastritis as a premalignant condition
28. Gastric cancer risk in chronic atrophic gastritis: Statistical calculations of cross-sectional data
29. Aspirin use and risk of fatal cancer
30. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer
31. Aspirin protects against gastric cancer: Results of a case-control study from Moscow, Russia
32. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori
33. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer
34. Helicobacter pylori eradication and antral intestinal metaplasia-two years follow-up study
35. Ole Moller Jensen Memorial Symposium on Nutrition and Cancer
36. Difficulty in eradicating Helicobacter pylori in a population at high risk for stomach cancer in Venezuela